SG/CALL/ABBOTT LABORATORIES/105/0.1/20.06.25 Stock

Warrant

DE000SW3WFV4

Delayed Deutsche Boerse AG 03:56:49 2024-07-01 EDT
0.98 EUR -1.01% Intraday chart for SG/CALL/ABBOTT LABORATORIES/105/0.1/20.06.25
Current month+8.79%
1 month+7.61%
Date Price Change
24-07-01 0.98 -1.01%
24-06-28 0.99 -4.81%
24-06-27 1.04 -3.70%
24-06-26 1.08 -0.92%
24-06-25 1.09 +0.93%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 03:56 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW3WFV
ISINDE000SW3WFV4
Date issued 2023-09-25
Strike 105 $
Maturity 2025-06-20 (355 Days)
Parity 10 : 1
Emission price 1.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.39
Lowest since issue 0.83
Delta0.57x
Omega 5.443
Premium11.57x
Gearing9.51x
Moneyness 0.9896
Difference Strike 1.09 $
Difference Strike %+1.04%
Spread 0.05
Spread %4.81%
Intrinsic value 0.000000

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.9 USD
Average target price
125.2 USD
Spread / Average Target
+20.45%
Consensus